Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells

Journal of Virology

Volumn 72, Issue 10, 1998, Pages 7733-7744

  Alterio De Goss, Mariagabriela ^a,b   Holtappels, Rafaela ^a   Steffens, Hans Peter ^a   Podlech, Jürgen ^a   Angele, Peter ^a   Dreher, Liane ^a   Thomas, Doris ^a   Reddehase, Matthias J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NONE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; CYTOMEGALOVIRUS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION;

EID: 3543144320     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.10.7733-7744.1998     Document Type: Article

References (51)

1. Azuma, M., M. Cayabyab, D. Buck, J. H. Philipps, and L. L. Lanier. 1992. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175:353-360.
2. Azuma, M., M. Cayabyab, J. H. Phillips, and L. L. Lanier. 1993. Requirements for CD28-dependent T cell-mediated cytotoxicity. J. Immunol. 150: 2091-2101.
3. Balthesen, M., M. Messerle, and M. J. Reddehase. 1993. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67:5360-5366.
4. Billingham, R. E., L. Brent, and P. B. Medawar. 1953. Actively acquired tolerance of foreign cells. Nature (London) 172:603-606.
5. Charlton, B., H. Auchincloss, Jr., and C. G. Fathman. 1994. Mechanisms of transplantation tolerance. Annu. Rev. Immunol. 12:707-734.
6. d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L. J. Exp. Med. 156:778-790.
7. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature (London) 312:548-550.
8. Cray, C., and R. B. Levy. 1989. The ability of murine cytomegalovirus and class I major histocompatibility complex-disparate parental cells to induce alterations characteristic of severe graft-versus-host reactions. Transplantation 48:1057-1063.
9. Cray, C., and R. B. Levy. 1993. CD8+ and CD4+ T cells contribute to the exacerbation of class I MHC disparate graft-vs-host reaction by concurrent murine cytomegalovirus infection. Clin. Immunol. Immunopathol. 67:84-90.
10. Einsele, H., H. Hebart, C. Bokemeyer, L. Kanz, G. Jahn, and C. A. Müller. 1998. Cytomegalovirus infection following hematopoietic stem cell transplantation. Monogr. Virol. 21:106-118.
11. Forman, S. J., and J. A. Zaia. 1994. Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation. Where do we stand? Blood 83:2392-2398.
12. George. J. F., S. D. Sweeney, J. K. Kirklin, E. M. Simpson. D. R. Goldstein, and J. M. Thomas. 1998. An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow. Nat. Med. 4:333-335.
13. Grundy, J. E., J. D. Shanley, and G. M. Shearer. 1985. Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis. Transplantation 39:548-553.
14. Hertenstein, B., W. Hampl, D. Bunjes, M. Wiesneth, C. Duncker, U. H. Koszinowski, H. Heimpel, R. Arnold, and T. Mertens. 1995. In vivo/ex vivo T cell depletion for GvHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT. Bone Marrow Transplant. 15:387-393.
15. Hill, R. S., F. B. Petersen, R. Storb, F. R. Appelbaum, K. Doney, S. Dahlberg, R. Ramberg, and E. D. Thomas. 1986. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood 67:811-816.
16. Ho, M. 1995. Cytomegaloviruses, p. 1351-1364. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingstone, New York, N.Y.
17. Holt, P. G., A. Degebrodt, T. Venaille, C. O'Leary, K. Krska, J. Flexman, H. Farrell, G. Shellam, P. Young, J. Pennale, T. Robertson, and J. M. Papadimitriou. 1985. Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays. Immunology 54:139-147.
18. Holtappels, R., J. Podlech, G. Geginat, H.-P. Steffens, D. Thomas, and M. J. Reddehase. 1998. Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates. J. Virol. 72:7201-7212.
19. Huss, R., H. J. Deeg, T. Gooley, E. Bryant, W. Leisenring, R. Clift, C. D. Buckncr, P. Martin, R. Storb, and F. R. Appelbaum. 1996. Effect of mixed chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Bone Marrow Transplant. 18:767-776.
20. Jondal, M., R. Schirmbeck, and J. Reimann. 1996. MHC class-I-restricted CTL responses to exogenous antigens. Immunity 5:295-302.
21. Keil, G. M., M. R. Fibi, and U. H. Koszinowski. 1985. Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus. J. Virol. 54:422-428.
22. Koszinowski, U. H., M. Del Val, and M. J. Reddehase. 1990. Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 154:189-220.
23. Koszinowski, U. H., M. J. Reddehase, and S. Jonjic. 1993. The role of T-lymphocyte subsets in the control of cytomegalovirus infection, p. 429-445. In D. B. Thomas (ed.), Viruses and the cellular immune response. Marcel Dekker, New York, N.Y.
24. Kranz, D. M., S. Tonegawa, and H. N. Eisen. 1984. Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 81:7922-7926.
25. Kurz, S., H.-P. Steffens, A. Mayer, J. R. Harris, and M. J. Reddehase. 1997. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71:2980-2987.
26. d class I major histocompatibility complex molecules determines their antigenic structure. J. Exp. Med. 173:449-459.
27. Ljungman, P. 1994. Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Bone Marrow Transplant. 13:209-212.
28. Mangioni, S., A. Balduzzi, A. Rivolta, A. Rovelli, F. Nesi, V. Rossi, A. Busca, C. Uderzo, R. Miniero, and A. Biondi. 1997. Long-term persistence of hemopoietic chimerism following sex-mismatched bone marrow transplantation. Bone Marrow Transplant. 20:969-973.
29. Mayer, A., J. Podlech, S. Kurz, H.-P. Steffens, S. Maiberger, K. Thalmeier, P. Angele, L. Dreher, and M. J. Reddehase. 1997. Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. J. Virol. 71:4589-4598.
30. Mutter, W., M. J. Reddehase, F. W. Busch, H.-J. Bühring, and U. H. Koszinowski. 1988. Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J. Exp. Med. 167:1645-1658.
31. Nikolic, B., and M. Sykes. 1997. Bone marrow chimerism and transplantation tolerance. Curr. Opin. Immunol. 9:634-640.
32. d gene acts as restriction element for LCMV-specific killer T cells. Nature (London) 297:415-417.
33. Petz, L. D., P. Yam, R. B. Wallace, A. D. Stock, G. de Lange, R. G. Knowlton, V. A. Brown, H. Donis-Keller, L. R. Hill, S. J. Forman, and K. G. Blume. 1987. Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood 70:1331-1337.
34. Podlech, J., R. Holtappels, N. Wirtz, H.-P. Steffens, and M. J. Reddehase. 1998. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. J. Gen. Virol., 79:2099-2104.
35. Podlech, J., H.-P. Steffens, R. Holtappels, A. Mayer, M. Alterio de Goss, O. Oettel, N. Wirtz, S. Maiberger, and M. J. Reddehase. 1998. Cytomegalovirus pathogenesis after experimental bone marrow transplantation. Monogr. Virol. 21:119-128.
36. Reddehase, M. J., S. Jonjic, F. Weiland, W. Mutter, and U. H. Koszinowski. 1988. Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. J. Virol. 62:1061-1065.
37. Reddehase, M. J., W. Mutter, and U. H. Koszinowski. 1987. In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection. J. Exp. Med. 165:650-656.
38. Reddehase, M. J., J. B. Rothbard, and U. H. Koszinowski. 1989. A penta-peptide as minimal antigenic determinant for MHC class-I-restricted T lymphocytes. Nature (London) 337:651-653.
39. Reddehase, M. J., F. Weiland, K. Münch, S. Jonjic, A. Lüske, and U. H. Koszinowski. 1985. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55:264-273.
40. Reusser, P., L. D. Fisher, C. D. Buckner, E. D, Thomas, and J. D. Meyers. 1990. Cytomegalovirus infection after autologous hone marrow transplantation: occurrence of cytomegalovirus disease and effect on engraftment. Blood 75:1888-1894.
41. Reusser, P., S. R. Riddell, J. D. Meyers, and P. D. Greenberg. 1991. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373-1380.
42. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238-241.
43. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195-200.
44. Rubocki, R. J., T. H. Hansen, and D. R. Lee. 1986. Molecular studies of murine mutant BALB/c-H-2-dm2 define a deletion of several class I genes including the entire H-2Ld gene. Proc. Natl. Acad. Sci. USA 83:9606-9610.
45. Salazar-Mather, T. P., J. S. Orange, and C. A. Biron. 1998. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J. Exp. Med. 187:1-14.
46. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126.
47. Steffens, H.-P., S. Kurz, R. Holtappels, and M. J. Reddehase. 1998. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence. J. Virol. 72:1797-1804.
48. Steffens, H.-P., J. Podlech, S. Kurz, P. Angele, D. Dreis, and M. J. Reddehase. 1998. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J. Virol. 72:5006-5115.
49. Sykes, M. 1996. Chimerism and central tolerance. Curr. Opin. Immunol. 8:694-703.
50. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038-1044.
51. Wingard, J. R., D. Y. Chen, W. H. Burns, D. J. Fuller, H. G. Braine, A. M. Yeager, H. Kaiser, P. J. Burke, M. L. Graham, and G. W. Santos. 1988. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 71:1432-1437.